A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Clinical trial NCT05091307 · COMPLETED

Trial details

NCT number: NCT05091307
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Prevention

Start date: 2021-11-02
Primary completion: 2022-06-17
Enrollment: 861

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.